Guidant
This article was originally published in The Gray Sheet
Executive Summary
Firm starts a 200-patient, 22-site clinical trial Dec. 4 evaluating the fifth-generation Multi-Link Penta coronary stent, which features enhanced retention and conformability. Guidant launched its fourth-generation Multi-Link Tetra on Oct. 3 (1"The Gray Sheet" Oct. 9, 2000, p. 16)